Annovis Bio completes $50 million public stock sale
May 28, 2021 at 10:26 AM EDT
Annovis Bio is developing a treatment for Parkinson's and Alzheimer's diseases.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|